ADIAL PHARMACEUTICALS, INC. (ADIL) › Cash & EquivalentsADIAL PHARMACEUTICALS, INC. (ADIL) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2016: $88.0K2017: $18.2K2018: $3.87M2019: $6.78M2020: $4.40M2021: $6.06M2022: $4.00M2023: $2.83M2024: $3.75M2025: $5.88M$5.88M2016Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$5.88M+56.8%2024$3.75M+32.7%2023$2.83M-29.4%2022$4.00M-34.0%2021$6.06M+37.7%2020$4.40M-35.1%2019$6.78M+75.2%2018$3.87M+21102.6%2017$18.2K-79.3%2016$88.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share